Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Xtandi Demonstrates Clinical Benefit for Advanced Breast Cancer in PII Study: Astellas
December 17, 2014
- Battle Begins for Blopress Generics
December 16, 2014
- Eliquis the First NOAC with Safety Information Announced for Over 100,000 Patients
December 16, 2014
- Kaketsuken, Teijin Pharma Initiate Voluntary Recall of Venilon after Wool Fiber Found in Vial of Dissolved Product
December 16, 2014
- Otsuka Initiates Tender Offer to Acquire All Outstanding Shares of Avanir for US$17 per Share
December 16, 2014
- ViiV Healthcare Files NDA for Triple-Combination HIV Agent in Japan
December 16, 2014
- With Mandatory CDISC-Based Submission Looming, CRO A2 Sees Soaring Orders from Japanese Drug Makers
December 16, 2014
- Sanofi Reiterates Alert on Proper Use of Jevtana; Five Deaths Reported Since Launch in September
December 15, 2014
- Sumitomo Dainippon Aims for NDA Filing for ADHD Treatment Dasotraline in FY2017 in US
December 15, 2014
- Kyowa Kirin Aims to Score Global Sales of 20 Billion Yen for Poteligeo in a Few Years: President Hanai
December 15, 2014
- Astellas Reduces Sales Offices from 159 to 109, Aims to Better Respond to Specific Needs in Each Region: President Hatanaka
December 12, 2014
- Hanshin Dispensing Holding Joins Forces with Convenience Store Lawson
December 12, 2014
- Brexpiprazole Improves Schizophrenia in PIII: Otsuka, Lundbeck
December 11, 2014
- Eisai’s Orexin Receptor Antagonist Improves Sleep Initiation, Maintenance in PII Study
December 11, 2014
- Blopress AG Will Lose Steam after Launch of Rival Generics, Sawai Pres. Predicts
December 11, 2014
- Ono, Kyowa Kirin, BMS to Conduct PI Study of Opdivo and Poteligeo as Combination Therapy in Patients with Solid Tumors
December 11, 2014
- Humanized Bispecific Antibody for Hemophilia A Effective in PI Study: Chugai
December 10, 2014
- Alfresa to Acquire More Shares of Pharmacy Chain Operator
December 10, 2014
- Ethical Drug Sales 1.1%, in October: Crecon Report
December 10, 2014
- Efficacy of Lenalidomide in Treatment-Naïve Patients with Multiple Myeloma Confirmed in Domestic PII Study: Celgene
December 10, 2014
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…